AI is changing the world. Don't stay behind. Clear summaries, community insight, delivered without the noise. Subscribe to never miss a beat.

Privacy

Contact

Back to all news

openai claude ai-safety healthcare-ai

'Too Dangerous to Release' Is Becoming AI's New Normal

time.com

April 25, 2026

5 min read

🔥🔥🔥🔥🔥

29/100

Summary

OpenAI announced GPT-Rosalind, an AI model for life sciences, which significantly outperforms existing models in chemistry, biology, and experimental design. Similar to Anthropic's Claude Mythos and OpenAI's GPT-5.4-Cyber, GPT-Rosalind is initially restricted to qualified customers through a trusted access program.

Key Takeaways

OpenAI announced GPT-Rosalind, an AI model focused on life sciences, which outperforms existing models in chemistry, biology, and experimental design tasks.
Access to GPT-Rosalind and other recent models is restricted to "qualified customers" through a "trusted access program" due to concerns about their powerful capabilities.
The rapid advancement of AI capabilities has led to calls for stricter external oversight, as private companies currently decide who can access potentially dangerous AI models.
Dual-use capabilities of AI tools present challenges, as the same technology can be used for beneficial research or malicious purposes, complicating the decision-making process for access restrictions.

Read original article

Community Sentiment

Negative

Concerns

The phrase 'too dangerous to release' has been used incorrectly in the past, leading to skepticism about its validity and implications for AI safety.
Concerns are raised that AI models are being released to select individuals, potentially exacerbating societal issues rather than ensuring safety.
The notion that AI is too dangerous to release is viewed as a marketing tactic rather than a genuine concern for public safety.